AG-13958
AG-13958 (AG-013958), a VEGFR tyrosine kinase inhibitor, is in clinical development with ST administration for treatment of choroidal neovascularization associated with age–related macular degeneration (AMD).
| Trivial name | AG-013958 |
| Catalog Number | S2211 |
| Molecular Formula | C26H22FN7O |
| CAS# | 319460-94-1 |
| Inchi | InChI=1S/C26H22FN7O/c1-16-13-25(34(2)33-16)26(35)30-24-15-19(7-10-21(24)27)29-18-6-9-20-22(31-32-23(20)14-18)11-8-17-5-3-4-12-28-17/h3-15,29H,1-2H3,(H,30,35)(H,31,32)/b11-8+ |
| Inchi Key | JXSVVZKPEDIRTN-DHZHZOJOSA-N |
| SMILES | CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)C=CC5=CC=CC=N5)F)C |
| Size | 2mg |
| Supplier Page | http://www.selleckchem.com/products/ag-13958.html |
| Additional Information | https://file.selleck.cn/downloads/struct/ag-13958-chemical-structure-s2211.gif |